PTK2 and cancer: Mounting evidence has demonstrated the role of FAK in promoting TME remodeling for tumor progression and worse malignancy through enhanced propagation of cancer cells and cancer-associated stromal cells, expanding angiogenesis, increased ECM deposition (mechanotranduction), elevated cell motility for metastasis malignancy, and establishment of immunosuppressive TME.